First Time Loading...

Abbvie Inc

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
Price: 149.06 USD -2.1% Market Closed
Updated: Sep 30, 2023

Intrinsic Value

Intrinsic Value History
Abbvie Inc

Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.

This feature available only with
Unlimited Plan

Sign up to access Abbvie Inc's intrinsic value history.

No restrictions, no limits.
All stocks, all tools.

Spot Contrarian Opportunities

Look for stocks that have been historically overvalued but are now trading below their intrinsic value.

Easily Identify Value Traps

Avoid stocks that are always undervalued and never reach their intrinsic value.

Find Strong Rebounds

Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.

Valuation Methods

There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.

DCF Value
Discounted Cash Flow

DCF Parameters:
Operating Model
Discount Rate
Forecast Period
Terminal Growth
DCF Input
DCF Input
DCF Input

Fundamental Analysis


Balance Sheet Decomposition
Abbvie Inc

Current Assets 28.9B
Cash & Short-Term Investments 8.8B
Receivables 11.5B
Other Current Assets 8.6B
Non-Current Assets 107B
Long-Term Investments 288m
PP&E 4.9B
Intangibles 95.1B
Other Non-Current Assets 6.2B
Current Liabilities 32.2B
Accounts Payable 27B
Other Current Liabilities 5.2B
Non-Current Liabilities 90.3B
Long-Term Debt 55.8B
Other Non-Current Liabilities 34.5B
Fundamental Scores

ABBV Profitability Score
Profitability Due Diligence

Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROE

Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

ABBV Solvency Score
Solvency Due Diligence

Abbvie Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
Average Interest Coverage

Abbvie Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 172.52 USD with a low forecast of 136.35 USD and a high forecast of 215.25 USD.

Price Target
136.35 USD
9% Downside
Price Target
172.52 USD
16% Upside
Price Target
215.25 USD
44% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape


ABBV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ABBV Return Decomposition
Main factors of price return

What is price return decomposition?

ABBV Price
Abbvie Inc

1M 1M
6M 6M
1Y 1Y
3Y 3Y
5Y 5Y
10Y 10Y
Annual Price Range
52w Low
52w High
Price Metrics
Average Annual Return 14.95%
Standard Deviation of Annual Returns 17.83%
Max Drawdown -31%
Shares Statistics
Market Capitalization 263B USD
Shares Outstanding 1 776 000 000
Percentage of Shares Shorted 0.71%


Last Video News
Abbvie Inc

Other Videos

Last Important Events
Abbvie Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.


Sentiment Analysis
Abbvie Inc

Last 7 Days
Last 30 Days
Last 90 Days

Company Profile

Abbvie Inc Logo
Abbvie Inc


United States of America



Market Cap

263B USD

Dividend Yield



AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The firm's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.


North Chicago
1 N Waukegan Rd




50 000


Chairman & CEO
Mr. Richard A. Gonzalez
Vice Chairman & Pres
Mr. Robert A. Michael
Vice Chairman of External Affairs & Chief Legal Officer
Ms. Laura J. Schumacher
Exec. VP & Chief Commercial Officer
Mr. Jeffrey Ryan Stewart
Exec. VP & CFO
Mr. Scott T. Reents
Exec. VP of Operations
Dr. Azita Saleki-Gerhardt Ph.D.
Show More
Sr. VP of R&D and Chief Scientific Officer
Dr. Thomas J. Hudson
VP of Investor Relations
Ms. Elizabeth Shea
Exec. VP, Gen. Counsel & Sec.
Mr. Perry C. Siatis
Exec. VP & Chief HR Officer
Mr. Timothy J. Richmond
Show Less

See Also

Other Stocks
What is the Intrinsic Value of one ABBV stock?

The intrinsic value of one ABBV stock under the Base Case scenario is 119.04 USD.

Is ABBV stock undervalued or overvalued?

Compared to the current market price of 149.06 USD, Abbvie Inc is Overvalued by 20%.